HAEMATO AG (XTER:HAEK) Debt-to-Asset : 0.02 (As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is HAEMATO AG Debt-to-Asset?

HAEMATO AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €0.3 Mil. HAEMATO AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was €2.5 Mil. HAEMATO AG's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was €183.4 Mil. HAEMATO AG's debt to asset for the quarter that ended in Jun. 2023 was 0.02.

HAEMATO AG Debt-to-Asset Historical Data

The historical data trend for HAEMATO AG's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HAEMATO AG Debt-to-Asset Chart

HAEMATO AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

0.01

0.02

HAEMATO AG Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Asset	Get a 7-Day Free Trial															0.07	-	0.03	0.02	0.02

Competitive Comparison of HAEMATO AG's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, HAEMATO AG's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HAEMATO AG's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HAEMATO AG's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where HAEMATO AG's Debt-to-Asset falls into.

HAEMATO AG Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

HAEMATO AG's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.212	+	2.464)	/	176.57
	=	0.02

HAEMATO AG's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.269	+	2.489)	/	183.448
	=	0.02

HAEMATO AG (XTER:HAEK) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

HAEMATO AG Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of HAEMATO AG's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

HAEMATO AG (XTER:HAEK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HAEMATO AG (XTER:HAEK) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

HAEK:Germany HAEK:Germany HAEK:Germany

Address

Lilienthalstrasse 5c, Schonefeld, DEU, D-12529

Website

https://www.haemato.ag

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.

HAEMATO AG (XTER:HAEK) Headlines

No Headlines